← FDA ENFORCEMENT
D-0388-2026Class I

ANTHONY TRINH, 123Herbals LLC

Recalling firm
ANTHONY TRINH, 123Herbals LLC
Product type
Drug
Status
Ongoing
Report date
2026-03-11
Distribution
USA nationwide
Firm state
CA
Product quantity
N/A
Initiated by
Voluntary: Firm initiated
SPEQ quality domain
Documentation & Change Control
Reason for recall

Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.

Product description

SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China

Code / lot info

All lots within expiry

Other recalls SPEQ maps to Documentation & Change Control
2026-07-22Class ID'Dioses Fruit Pops, Inc.2026-07-22Class IIFayus Inc.2026-07-22Class ID'Dioses Fruit Pops, Inc.2026-07-22Class ID'Dioses Fruit Pops, Inc.
See all Documentation & Change Control recalls →

Data: U.S. FDA openFDA enforcement API. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification.